Vensa-PDH Partnership will Introduce Data Science to Primary Healthcare

Vensa-PDH Partnership will Introduce Data Science to Primary Healthcare

MEDIA RELEASE

Vensa partners with Precision Driven Health to introduce clinical data science to primary healthcare

Innovative technology to automate the retrieval of lab results and analyse patterns for patient notifications on vensa.com is the focus of Vensa’s first PDH project

AUCKLAND, NZ, 24 September 2018
 – Vensa Health (www.vensa.com), a leading New Zealand digital health company, has joined forces with research initiative Precision Driven Health (PDH) to research and develop new technology which will focus on the clinical transformation journey for primary care providers. The technology aims to optimise clinical time and clinical decision making as well as increase capability and capacity for primary care clinicians.

The project is part of Vensa’s vision to make primary care more accessible, affordable and convenient via the vensa.com platform.

Precision Driven Health’s General Manager, Dr Kevin Ross, says: “Precision Driven Health is delighted to be working with Vensa towards a shared goal of creating a more accurate, personalised and efficient health system. We wholeheartedly support Vensa’s vision and this project really stood out as shared lab results is an area where data could be more meaningfully used to better deliver healthcare in New Zealand.”

Vensa Health CEO, Ahmad Jubbawey, says the partnership accelerates the development of clinical process optimisation efforts – the third wave in Vensa’s 10 year vision plan that the company recently released.

“Our first project with Precision Driven Health aims to provide valuable insight into analysing lab results with AI that will learn the clinical guidelines of the clinician. This will help to detect uncommon lab trends and even disseminate lab results on behalf of clinicians to patients. We already have clinical leadership committed to helping with research and development,” he says.

Clinical laboratory testing plays a crucial role in clinical care, from screening of patients to monitoring both chronic and acute conditions. Tens of thousands of lab tests are ordered in primary care and processed daily across New Zealand. This equates to millions of lab test results to be interpreted by clinicians and explained to patients on a yearly basis, resulting from around 18 million annual GP visits.

Jubbawey says, “Working closely with primary care organisations we saw an opportunity to retrieve lab results data from patient management systems (PMS) and other sources to help clinicians and patients alike.”

Dr Jason Hwang, a global expert in disruptive healthcare innovation who co-authored The Innovator’s Prescription: A Disruptive Solution for Health Care with Clayton Christensen, and a Principal Investigator of the study says, “The project aims to accurately automate and disseminate lab results to improve clinical decision making and save a clinician’s time. We’re also interested in how insights from collective clinical best practice could be used to identify lab results patterns from longitudinal trends that could lead to new recommendations for interpreting individual lab results.”

“There is great value to be gained from using technology to automate and analyse lab results and deliver these accurately, inexpensively and in a timely matter to patients via patient alerts. Globally, an increasing number of patients are becoming proponents of new digital health tools that improve and personalise medical care, and disruptive innovation like this will help meet those needs.”

Jubbawey, says the project has the potential to advance the role of automation and AI in clinical decision making and dramatically improve a clinician’s workload at the same time.

“I have had many GPs come to me and say that they are working until midnight every day to process lab results. Providing GPs with a tool that extends their clinical guidelines will free up a lot of valuable time. It’s really exciting for us to help serve primary care providers as part of the vensa.com suite.”

Precision Driven Health was set up to support a thriving health IT capability in New Zealand, applying data science to develop tools that improve health.

Dr Ross says, “Vensa are an ideal partner for us as they’re a successful health IT business with plans to export globally. Vensa have already demonstrated a clear pathway from research to development and implementation, firstly with TXT2Remind which is used by close to 70% of GP practices in the country, and more recently with their platform vensa.com which targets a new delivery model for healthcare which this research supports.”

The three-year research project commences this month. For further information, please visit precisiondrivenhealth.com for the project summary.

ENDS

More Information

Sandra Lukey, Shine Group (PR for Vensa Health)
email: sandra@shinegroup.co.nz; cell: 021 2262 858;

Dr Kevin Ross, General Manager, Precision Driven Health
email: kevin@precisiondrivenhealth.com; cell: 027 771 2337

About Vensa Health
Vensa Health is a leading digital health solutions provider in New Zealand.  Over 650 General Practice customers in New Zealand use technology developed by Vensa Health, to deliver health messages and appointments to over 3 million Kiwis a year.  Vensa.com ensures patients are better connected to their health provider, allowing appointments to be booked online in real-time anytime, repeat prescriptions to be ordered and paid for online, and a range of other innovative health services. The Vensa.com platform also enables the delivery of mobile health innovations worldwide. For more on Vensa Health see www.vensahealth.com

About Precision Driven Health
Precision Driven Health is a seven-year NZ$38 million research partnership aimed at improving health outcomes through data science. It is co-founded by Orion Health, Waitemata District Health Board and the University of Auckland. The initiative positions New Zealand at the forefront of the global transformation in healthcare known as precision medicine or personalised medicine. Precision Medicine is enabled when all information about an individual – including his or her genetic and social profile – is available as part of an electronic health record which can be accessed by clinicians in real time. For more on Precision Driven Health, see www.precisiondrivenhealth.com

PDH is New Zealand’s unique health data science research partnership.